Senior Clinical Research Coordinator, Cellular Therapy

University-of-North-Carolina-At-Chapel-Hil; Chapel Hill (NC); On-site; USD 60,000 - 75,000; Full time

Benefits offered by this job

Comprehensive benefits package

Paid leave

Health, life and retirement plans

Job summary

University of North Carolina at Chapel Hill is seeking a Senior Clinical Research Participant Coordinator for the Cellular Therapy Program within Lineberger Comprehensive Cancer Center. The role coordinates complex clinical research protocols, manages participant data, and liaises with study teams and clinical staff to integrate research with care.

The position requires initiative, planning and independent evaluation of data collection methods, and experience in early-phase cancer trials is

Qualifications

• Bachelor’s degree in a discipline related to the field and one year of related training or experience.
• Ability to independently plan, organize and evaluate clinical research participant management.
• Experience coordinating between study staff, participants and clinical staff.

Responsibilities

• Plan, organize and evaluate clinical research participant management and data collection for complex protocols.
• Liaise between study staff, participants, and clinical staff to ensure smooth study operations.
• Support integration of research activities into the clinical care environment and educate clinical staff.

Skills

Data collection

Participant coordination

Liaising with staff

Education coordination

Education

Bachelor’s degree in related field

Job description

University of North Carolina at Chapel Hill is seeking a Senior Clinical Research Participant Coordinator for the Cellular Therapy Program within Lineberger Comprehensive Cancer Center. The role coordinates complex clinical research protocols, manages participant data, and liaises with study teams and clinical staff to integrate research with care.

The position requires initiative, planning and independent evaluation of data collection methods, and experience in early-phase cancer trials is